Chen, Fenfang, Yujiao Han, and Yibin Kang. (2021) 2021. “Bone Marrow Niches in the Regulation of Bone Metastasis”. Br J Cancer 124 (12): 1912-20. doi:10.1038/s41416-021-01329-6.

Spadazzi, Chiara, Laura Mercatali, Mark Esposito, Yong Wei, Chiara Liverani, Alessandro De Vita, Giacomo Miserocchi, et al. (2021) 2021. “Trefoil Factor-1 Upregulation in Estrogen-Receptor Positive Breast Cancer Correlates With an Increased Risk of Bone Metastasis”. Bone 144: 115775. doi:10.1016/j.bone.2020.115775.

Esposito, Mark, Cao Fang, Katelyn Cook, Nana Park, Yong Wei, Chiara Spadazzi, Dan Bracha, et al. (2021) 2021. “TGF-β-Induced DACT1 Biomolecular Condensates Repress Wnt Signalling to Promote Bone Metastasis”. Nat Cell Biol 23 (3): 257-67. doi:10.1038/s41556-021-00641-w.

Fang, Cao, and Yibin Kang. (2022) 2022. “Cellular Plasticity in Bone Metastasis”. Bone 158: 115693. doi:10.1016/j.bone.2020.115693.

Peng, Jia, and Yibin Kang. (2017) 2017. “The Bony Side of Endothelial Cells in Prostate Cancer”. Dev Cell 41 (5): 451-52. doi:10.1016/j.devcel.2017.05.015.

Zheng, Hanqiu, Yangjin Bae, Sabine Kasimir-Bauer, Rebecca Tang, Jin Chen, Guangwen Ren, Min Yuan, et al. (2017) 2017. “Therapeutic Antibody Targeting Tumor- and Osteoblastic Niche-Derived Jagged1 Sensitizes Bone Metastasis to Chemotherapy”. Cancer Cell 32 (6): 731-747.e6. doi:10.1016/j.ccell.2017.11.002.

Kang, Yibin, Peter Siegel, Weiping Shu, Maria Drobnjak, Sanna Kakonen, Carlos Cordón-Cardo, Theresa Guise, and Joan Massagué. (2003) 2003. “A Multigenic Program Mediating Breast Cancer Metastasis to Bone.”. Cancer Cell 3 (6): 537-49.

Kang, Yibin. (2006) 2006. “Pro-Metastasis Function of TGFbeta Mediated by the Smad Pathway.”. J Cell Biochem 98 (6): 1380-90. doi:10.1002/jcb.20928.

Kang, Yibin, Wei He, Shaun Tulley, Gaorav Gupta, Inna Serganova, Chang-Rung Chen, Katia Manova-Todorova, Ronald Blasberg, William Gerald, and Joan Massagué. (2005) 2005. “Breast Cancer Bone Metastasis Mediated by the Smad Tumor Suppressor Pathway.”. Proc Natl Acad Sci U S A 102 (39): 13909-14. doi:10.1073/pnas.0506517102.

Lu, Xin, and Yibin Kang. (2009) 2009. “Efficient Acquisition of Dual Metastasis Organotropism to Bone and Lung through Stable Spontaneous Fusion Between MDA-MB-231 Variants.”. Proc Natl Acad Sci U S A 106 (23): 9385-90. doi:10.1073/pnas.0900108106.

Zhu, Ji, Xun Jia, Guozhi Xiao, Yibin Kang, Nicola Partridge, and Ling Qin. (2007) 2007. “EGF-Like Ligands Stimulate Osteoclastogenesis by Regulating Expression of Osteoclast Regulatory Factors by Osteoblasts: Implications for Osteolytic Bone Metastases.”. J Biol Chem 282 (37): 26656-64. doi:10.1074/jbc.M705064200.

Lu, Xin, and Yibin Kang. (2007) 2007. “Organotropism of Breast Cancer Metastasis.”. J Mammary Gland Biol Neoplasia 12 (2-3): 153-62. doi:10.1007/s10911-007-9047-3.

Lu, Xin, and Yibin Kang. (2009) 2009. “Metalloproteinases and Osteoblast EGFR Signaling in Osteolytic Bone Metastasis of Breast Cancer.”. Cell Cycle 8 (23): 3804-5. doi:10.4161/cc.8.23.10104.

Lu, Xin, Qiongqing Wang, Guohong Hu, Catherine Van Poznak, Martin Fleisher, Michael Reiss, Joan Massagué, and Yibin Kang. (2009) 2009. “ADAMTS1 and MMP1 Proteolytically Engage EGF-Like Ligands in an Osteolytic Signaling Cascade for Bone Metastasis.”. Genes Dev 23 (16): 1882-94. doi:10.1101/gad.1824809.

Korpal, Manav, Jun Yan, Xin Lu, Shuwa Xu, Dorothy Lerit, and Yibin Kang. (2009) 2009. “Imaging Transforming Growth Factor-Beta Signaling Dynamics and Therapeutic Response in Breast Cancer Bone Metastasis.”. Nat Med 15 (8): 960-6. doi:10.1038/nm.1943.

Sethi, Nilay, Xudong Dai, Christopher Winter, and Yibin Kang. (2011) 2011. “Tumor-Derived JAGGED1 Promotes Osteolytic Bone Metastasis of Breast Cancer by Engaging Notch Signaling in Bone Cells.”. Cancer Cell 19 (2): 192-205. doi:10.1016/j.ccr.2010.12.022.

Sethi, Nilay, and Yibin Kang. (2011) 2011. “Dysregulation of Developmental Pathways in Bone Metastasis.”. Bone 48 (1): 16-22. doi:10.1016/j.bone.2010.07.005.

Lu, Xin, Carol Yan, Min Yuan, Yong Wei, Guohong Hu, and Yibin Kang. (2010) 2010. “In Vivo Dynamics and Distinct Functions of Hypoxia in Primary Tumor Growth and Organotropic Metastasis of Breast Cancer.”. Cancer Res 70 (10): 3905-14. doi:10.1158/0008-5472.CAN-09-3739.

Lu, Xin, Euphemia Mu, Yong Wei, Sabine Riethdorf, Qifeng Yang, Min Yuan, Jun Yan, et al. (2011) 2011. “VCAM-1 Promotes Osteolytic Expansion of Indolent Bone Micrometastasis of Breast Cancer by Engaging α4β1-Positive Osteoclast Progenitors.”. Cancer Cell 20 (6): 701-14. doi:10.1016/j.ccr.2011.11.002.

Ibrahim, Toni, Emanuele Sacanna, Michele Gaudio, Laura Mercatali, Emanuela Scarpi, Wainer Zoli, Patrizia Serra, et al. (2011) 2011. “Role of RANK, RANKL, OPG, and CXCR4 Tissue Markers in Predicting Bone Metastases in Breast Cancer Patients.”. Clin Breast Cancer 11 (6): 369-75. doi:10.1016/j.clbc.2011.05.001.

Mercatali, Laura, Toni Ibrahim, Emanuele Sacanna, Emanuela Flamini, Emanuela Scarpi, Daniele Calistri, Marianna Ricci, et al. (2011) 2011. “Bone Metastases Detection by Circulating Biomarkers: OPG and RANK-L.”. Int J Oncol 39 (1): 255-61. doi:10.3892/ijo.2011.1001.

Liang, Yajun, Heng Wu, Rong Lei, Robert Chong, Yong Wei, Xin Lu, Ilias Tagkopoulos, et al. (2012) 2012. “Transcriptional Network Analysis Identifies BACH1 As a Master Regulator of Breast Cancer Bone Metastasis.”. J Biol Chem 287 (40): 33533-44. doi:10.1074/jbc.M112.392332.

Andres Blanco, Mario, Gary LeRoy, Zia Khan, Maša Alečković, Barry Zee, Benjamin Garcia, and Yibin Kang. (2012) 2012. “Global Secretome Analysis Identifies Novel Mediators of Bone Metastasis.”. Cell Res 22 (9): 1339-55. doi:10.1038/cr.2012.89.

Ell, Brian, and Yibin Kang. (2012) 2012. “SnapShot: Bone Metastasis.”. Cell 151 (3): 690-690.e1. doi:10.1016/j.cell.2012.10.005.

Wang, Yufeng, Rong Lei, Xueqian Zhuang, Ning Zhang, Hong Pan, Gang Li, Jing Hu, et al. (2014) 2014. “DLC1-Dependent Parathyroid Hormone-Like Hormone Inhibition Suppresses Breast Cancer Bone Metastasis.”. J Clin Invest 124 (4): 1646-59. doi:10.1172/JCI71812.

Esposito, Mark, and Yibin Kang. (2014) 2014. “Targeting Tumor-Stromal Interactions in Bone Metastasis.”. Pharmacol Ther 141 (2): 222-33. doi:10.1016/j.pharmthera.2013.10.006.

Ell, Brian, Laura Mercatali, Toni Ibrahim, Neil Campbell, Heidi Schwarzenbach, Klaus Pantel, Dino Amadori, and Yibin Kang. (2013) 2013. “Tumor-Induced Osteoclast MiRNA Changes As Regulators and Biomarkers of Osteolytic Bone Metastasis.”. Cancer Cell 24 (4): 542-56. doi:10.1016/j.ccr.2013.09.008.

Ren, Guangwen, Mark Esposito, and Yibin Kang. (2015) 2015. “Bone Metastasis and the Metastatic Niche.”. J Mol Med (Berl) 93 (11): 1203-12. doi:10.1007/s00109-015-1329-4.

Zheng, Hanqiu, and Yibin Kang. (2015) 2015. “Cradle of Evil: Osteogenic Niche for Early Bone Metastasis.”. Cancer Cell 27 (2): 153-5. doi:10.1016/j.ccell.2015.01.006.

Chakrabarti, Rumela, and Yibin Kang. 2015. “Transplantable Mouse Tumor Models of Breast Cancer Metastasis.”. Methods Mol Biol 1267: 367-80. doi:10.1007/978-1-4939-2297-0_18.

Bednarz-Knoll, Natalia, Antonia Efstathiou, Frauke Gotzhein, Harriet Wikman, Volkmar Mueller, Yibin Kang, and Klaus Pantel. (2016) 2016. “Potential Involvement of Jagged1 in Metastatic Progression of Human Breast Carcinomas.”. Clin Chem 62 (2): 378-86. doi:10.1373/clinchem.2015.246686.